PhageTech

PhageTech, Inc. is a developmental stage company based in Irvine, California. With a small team of three employees, the company is focused on revolutionizing disease detection. PhageTech develops innovative diagnostic tools that identify disease markers in bodily fluids such as urine and blood. Their technology, which utilizes phage-based assays instead of traditional antibody-based methods, aims to provide improved sensitivity, performance, stability, and cost-effectiveness compared to existing testing methods. This technology holds the potential to significantly impact the diagnosis of conditions like prostate cancer and kidney disease. PhageTech's core technology originated from research conducted at the University of California, Irvine, and is protected by multiple patents. The company's platform has demonstrated successful protein sensing with PSMA (Prostate-specific membrane antigen) and HSA (Human Serum Albumin), two crucial targets in disease diagnosis. For more information about PhageTech and their groundbreaking diagnostic solutions, visit their website at phagetech.com.